Fulminant immune-mediated necrotising myopathy (IMNM) mimicking myocardial infarction with non-obstructive coronary arteries (MINOCA)

Sophie Glenn-Cox, Robert William Foley, John D. Pauling, Jonathan C.L. Rodrigues

Research output: Contribution to journalArticlepeer-review

1 Citation (SciVal)
41 Downloads (Pure)

Abstract

A 74-year-old man, with inflammatory arthritis, recently commenced on adalimumab, presented with a 4-week history of left-sided chest pain, malaise and shortness of breath. Admission ECG showed age-indeterminate left bundle branch block. Troponin T was 4444 ng/L (normal range 15 ng/L) and acute coronary syndrome treatment was commenced. Catheter angiogram revealed mild-burden non-obstructive coronary disease. Cardiac magnetic resonance (CMR) was performed to refine the differential diagnosis and demonstrated no myocardial oedema or late gadolinium enhancement. Extracardiac review highlighted oedema and enhancement of the left shoulder girdle muscles consistent with acute myositis. Creatine kinase was subsequently measured and significantly elevated at 7386 IU/L (normal range 30-200 IU/L in men). Electrophoresis clarified that this was of predominantly skeletal muscle origin. Myositis protocol MRI revealed florid skeletal muscle oedema. The MR findings, together with positive anti-Scl-70 antibodies, suggested fulminant immune-mediated necrotising myopathy presenting as a rare mimic of myocardial infarction with non-obstructive coronary arteries, diagnosed by careful extracardiac CMR review.

Original languageEnglish
Article numbere236603
JournalBMJ Case Reports
Volume13
Issue number11
Early online date2 Nov 2020
DOIs
Publication statusPublished - 2 Nov 2020

Keywords

  • cardiovascular medicine
  • radiology
  • rheumatology

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Fulminant immune-mediated necrotising myopathy (IMNM) mimicking myocardial infarction with non-obstructive coronary arteries (MINOCA)'. Together they form a unique fingerprint.

Cite this